Potential vascular and bleeding complications of treatment with selective serotonin reuptake inhibitors

Psychosomatics

Volumn 37, Issue 1, 1996, Pages 12-16

  Skop, Brian P ^a   Brown, Thomas M ^a  

^a WILFORD HALL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE; SEROTONIN; SEROTONIN RECEPTOR; SEROTONIN UPTAKE INHIBITOR;

BLEEDING; BLOOD VESSEL TONE; HUMAN; REVIEW; SEROTONINERGIC SYSTEM; THROMBOCYTE AGGREGATION; VASOSPASM;

EID: 0030050198     PISSN: 00333182     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0033-3182(96)71592-X     Document Type: Review

References (41)

1. Rickels K, Schweizer E: Clinical overview of serotonin reuptake inhibitors. J Clin Psychiatry 1990; 51(suppl B):9-12
2. Stahl SM: Serotonergic mechanisms and the new antidepressants (editorial). Psychol Med 1993; 23:281-285
3. Prichard BN, Smith CC: Serotonin: receptors and antagonists - summary of symposium. Clinical Physiology & Biochemistry 1990; 8(suppl 3):120-128
4. Stahl SM: Platelets as pharmacologic models for the receptors and biochemistry of monoaminergic neurons, in The Platelets: Physiology and Pharmacology, edited by Longenecker GL. Ortando, FL, Academic Press, 1985, pp 307-340
5. Lingjaerde O: Blood platelets as a model system for studying serotonergic dysfunction and effects of antidepressants. Pharmacol Toxicol 1990; 66(suppl 3):61-68
6. Fricchione GL, Woznicki RM, Klesmer J, et al: Vasoconstrictive effects and the SSRIs. J Clin Psychiatry 1993; 54:71-72
7. Spier SA, Frontera MA: Unexpected deaths in depressed medical inpatients treated with fluoxetine. J Clin Psychiatry 1991; 52:377-388
8. Buff DD, Brenner R, Kirtane SS, et al: Dysrhythmia associated with fluoxetine treatment in an elderly patient with cardiac disease. J Clin Psychiatry 1991; 52:174-176
9. Gardner SF, Rutherford WF, Munger MA, et al: Drug-induced supraventricular tachycardia: a case report of fluoxetine. Ann Emerg Med 1991; 20:194-197
10. Ottervanger JP, van den Beim PM, de Koning GH, et al: Risk of hemorrhage with the use of fluoxetine (Prozac) or fluvoxamine (Fevarin). Nederl Tijdschr Geneeskd 1993; 137:259-261
11. Varyura-Tobias JA, Kirschen H, Nnan P, et al: Fluoxetine and bleeding in obsessive-compulsive disorder (letter). Am J Psychiatry 1991; 148:949
12. Aranth J, Lindberg C: Bleeding, a side effect of fluoxetine (letter). Am J Psychiatry 1992; 149:412
13. Gunzberger DW, Martinez D: Adverse vascular effects associated with fluoxetine. Am J Psychiatry 1992; 149:1751
14. Alderman CP, Moritz CK, Ben-Tovim DI: Abnormal platelet aggregation associated with fluoxetine therapy. Ann Pharmacother 1992; 26:1517-1519
15. Humphries JE, Wheby MS, VandenBerg SR: Fluoxetine and the bleeding time. Arch Pathol Lab Med 1990; 114:728-731
16. Onervanger JP, Stricker BCCH, Huls J, et al: Bleeding attributed to the intake of paroxetine. Am J Psychiatry 1994; 151:781-782
17. Evans TG, Buys SS, Rodgers GM: Untitled (letter). N Engl J Med 1991; 324:1671
18. Tyce GM: Origin and metabolism of serotonin. J Cardiovasc Pharmacol 1990; 16 (suppl 3):51-57
19. Verbeuren TJ: Synthesis, storage, release and metabolism of 5-hydroxytryptamine in peripheral tissues, in The Peripheral Actions of 5-Hydroxytryptamine. edited by Fozard JR. New York, Oxford University Press, 1989, pp 1-25
20. Artigas F, Sarrias MJ, Martinez E, et al: Serotonin in body fluids: characterization of human and cerebrospinal fluid pools by means of a new HPLC method. Life Sci 1985: 37:441-447
21. Ortiz J, Artigas F: Effects of monoamine uptake inhibitors on extracellular and platelet 5-hydroxytryptamine in rat blood: different effects of clomipramine and fluoxetine. Br J Pharmacol 1992; 105:941-946
22. Celada P, Dolera M, Alvarez E, et al: Effects of acute and chonic treatment with fluvoxamine on extracellular and platelet serotonin in the blood of major depressive patients. Relationship to clinical improvement. J Affect Disord 1992; 25:243-249
23. Ross SB, Aperia B, Beck-Friis J, et al: Inhibition of 5-hydroxytryptamine uptake in human platelets by antidepressant agents in vivo. Psychopharmacology 1980; 67:1-7
24. Tyrer SP, Marshall EF, Griffiths HW: The relationship between response to fluoxetine, plasma drug levels, imipramine binding to platelet membranes and whole-blood 5-HT. Prog Neuropsychopharmacol Biol Psychiatry 1990; 14:797-805
25. Muck-Seler D, Jakovljevic M, Deanovic Z: Effect of antidepressant treatment on platelet 5-HT content and relation to therapeutic outcome in unipolar depressive patients. J Affect Disord 1991; 23:157-164
26. Hoeksema T, Goekoop JG, Van Kempen GM: Effects of fluvoxamine on whole-blood serotonin and platelet number (letter). J Clin Psychopharmacol 1993; 13:75-76
27. Kuhs H, Schlake HP, Rolf LH, et al: Relationship between parameters of serotonin transport and antidepressant plasma levels on therapeutic response in depressive patients treated with paroxetine and amitriptyline. Acta Psychiatr Scand 1992; 85:364-369
28. Skop BP, Finkelstein JA, Mareth TR, et al: The serotonin syndrome associated with paroxetine, an over-the-counter cold remedy, and vascular disease: a case report and review. Am J Emerg Med 1994; 12:642-644
29. Hourani SM, Cusack NJ. Pharmacologic receptors on blood platelets. Pharmacol Rev 1991; 43:243-298
30. DeClerck F: The role of serotonin in thrombogenesis. Clinical Physiology & Biochemistry 1991; 8 (suppl 3):40-49
31. Fluoxetine, Paroxetine, Sertraline. Physicians' Desk Reference. Oradell, NJ, Medical Economics, 1994
32. McCall RB, Patel BN, Harris LT: Effects of serotonin, and serotoninrMDSD_2 receptor agonists and antagonists on blood pressure, heart rate, and sympathetic nerve activity. J Pharmacol Exp Ther 1987; 242:1152-1159
33. Gillis RA, Hill KJ, Kirby JS, et al: Effect of activation of central nervous system serotonin 1A receptors on cardiorespiratory function. J Pharmacol Exp Ther 1989;851-857
34. Luscher TF, Richard V, Tschudi M, et al: Serotonin and the endothelium. Clinical Physiology & Biochemistry 1990; 8 (suppl 3): 108-119
35. 3 receptor agents. Pharmacol Rev 1991; 43:579-586
36. Hillis WS, MacIntyre PD: Sumatriptan and chest pain. Lancet 1993: 341:1564-1565
37. Ku DD: Coronary vascular reactivity after acute myocardial infarction. Science 1982; 218:576-578
38. Luscher TF, Vanhoutte PM: Endothelium-dependent responses to aggregating platelets and serotonin in spontaneously hypertensive rats. Hypertension 1986: 8(suppl 2):55-60
39. Shimokawa H, Vanhoutte PM: Impaired endothelium-dependent relaxation to aggregating platelets and related vasoactive substances in porcine coronary arteries in hypercholesterolemia and atherosclerosis. Circ Res 1989; 64:900-914
40. Fisch C, Knoebel SB: Electrocardiographs findings in sertraline depression trials. Drug Investigations 1992; 4:305-312
41. Warrington SJ. Clinical implications of the pharmacology of sertraline. Int Clin Psychopharmacol 1991; 6(suppl 2): 11-21